
Psilocybin Aging Study: What the 2025 Mouse Research Found
By Lily Pelenis / November 20, 2026 / 7 min read
“Mushrooms might be anti-aging now?” was the subject line of our newsletter in July 2025, and the question mark was doing a lot of work. The psilocybin aging study behind it found that psilocin helped human cells in the lab keep dividing for longer, and that more old mice given psilocybin were alive at the end of 10 months: 80% against 50%. It was a cell and mouse study, so it tells us nothing yet about whether psilocybin slows aging in people.
TLDR
Researchers from Emory University and Baylor College of Medicine published the study in npj Aging in July 2025. In human lung cells, psilocin extended the cells’ lifespan by 29% at a lower dose and 57% at a higher one. Skin cells showed a 51% gain at the higher dose.
In 58 old female mice, 24 of 30 given monthly psilocybin were alive after 10 months, against 14 of 28 untreated mice. The treated mice also looked better, with fuller fur and fewer white hairs, though that was not measured.
The study was small, used one sex, was not blinded and stopped when half the untreated mice had died. No one has tested psilocybin for aging in humans, and it is not approved for anything in Canada.
Quick facts
- 29% to 57%
- longer lifespan for lung cells in a dish
- 80% vs 50%
- old mice still alive after 10 months
- 19 months
- mouse age at start, like 60 to 65
- 0
- human studies of psilocybin and aging
Who this article is for
- You saw a headline saying magic mushrooms slow aging and want to know what was actually tested.
- You are over 50 and wondering whether psilocybin belongs in your longevity plans.
- You like reading the study before you believe the summary.
- You already microdose and want to know whether this research applies to you.
Lily Pelenis
Author’s note
This piece began as a letter to our newsletter readers in July 2025. We had just read a paper that surprised us: a psychedelic tested not for the mind but for aging cells and old mice. Longevity headlines travel fast, and this paper sits behind many of them.
I am a Toronto-based lifestyle coach and yoga instructor, and I have used psilocybin for over a decade. I love nature, psychology and people, and I also love a good study. This one is exciting and very early, and I want you to have both halves of that sentence.
What did the psilocybin aging study find?
It found longer-lived cells in a dish and better survival in old mice. Both results come from one paper by Kato and colleagues (2025) in npj Aging, which is free to read in full text.
In human cells
The team grew human fetal lung cells, a standard model of cell aging, with psilocin or without it. Psilocin is what the body turns psilocybin into. Cells normally divide a set number of times and then stop, a state called senescence. With psilocin, they kept going longer: 29% longer at the lower dose and 57% at the higher dose. Adult skin cells gained 51%.
The treated cells also showed less oxidative stress, a type of chemical wear, and their telomeres held their length. Telomeres are the protective caps on the ends of chromosomes that shorten as cells age.
In old mice
The mice were 19 months old at the start, which the authors compare to 60 to 65 human years. Thirty got psilocybin by mouth once a month for 10 months: 5 mg per kg of body weight the first time, then 15 mg per kg. Twenty-eight got a salt-water control.
When the study ended, 80% of the treated mice were alive against 50% of the controls. The authors also saw better fur, regrowth and fewer white hairs in treated mice, but did not measure it.
| Test | What was used | Result | Size |
|---|---|---|---|
| Lung cells, lower dose | Psilocin 10 µM | 29% longer cell lifespan | Lab cultures |
| Lung cells, higher dose | Psilocin 100 µM | 57% longer cell lifespan | Lab cultures |
| Skin cells, higher dose | Psilocin 100 µM | 51% longer cell lifespan | Lab cultures |
| Old female mice | Psilocybin monthly, 10 doses | 24 of 30 alive vs 14 of 28 | 58 mice |
In the mouse test, 24 of 30 treated mice were alive after 10 months, against 14 of 28 untreated mice.
How might psilocybin affect aging?
The authors suggest psilocin may slow the signals that push cells into senescence. In their cells, it raised SIRT1, a protein tied to cell aging and stress responses, and lowered markers of oxidative stress and DNA damage.
The mind and body link
The study grew out of what the authors call the psilocybin-telomere hypothesis. Their paper points to research linking depression and chronic stress with shorter telomeres, and positive mental states with longer ones. Since psilocybin is studied for depression, they asked whether it might touch biological aging too.
This is where our July letter found its heart: the idea that mental suffering leaves marks on the body. I find it a beautiful idea, and it remains a hypothesis. The cells in this study were not stressed or depressed. They were lab cultures.
What are the limits of the study?
The limits are big, and I am glad the authors name several of them. The work is preclinical, which means it happened in cells and animals before any human testing.
Small, one sex and not blinded
There were 58 mice, all female, and the paper says researchers were not blinded to which mice got psilocybin. All mice were euthanized at 10 months, when one group reached 50% deaths, so we do not know whether treated mice lived longer overall or only died later. The Emory news release calls it a 30% increase in survival, measured at that point.
All the mice were put down at 10 months, so the study shows who was alive then, not how long they could have lived.
Doses that do not map to people
The authors scaled a 25 mg human dose to about 5 mg per kg for mice, then used 15 mg per kg because mice clear psilocin faster. The cell doses were set in a dish. To me, neither tells us what a person would need, if anything.
A question the authors raise
Cells that keep dividing longer raise a cancer question. The treated cells did stop dividing in the end, but the authors say future work should check long-term cancer risk.
Lily’s take
I get excited by studies like this, and then I remind myself that mice are not little people. Sleep, movement, food and friendship are still my longevity plan, and none of them needed a mouse trial.
Does this mean psilocybin slows aging in people?
No. Nobody has tested psilocybin for aging in humans, and in the Emory release a co-investigator says its effects in aging populations still need study.
What we know about older people and psilocybin
The human research on age is about the trip, not about lifespan. In a 2024 study I wrote up in how age changes a psilocybin experience, adults over 60 felt weaker acute effects. Health Canada notes that magic mushrooms raise heart rate and blood pressure, and that no psilocybin product is approved.
Long-term use has its own questions
Taking psilocybin regularly for years has not been studied for safety. A 2023 analysis by Tagen and colleagues concluded that heart valve damage is a potential risk of long-term microdosing that needs research. Lithium, antidepressants and heart medicines also call for a doctor’s view; 47% of 62 reports of psychedelics with lithium involved seizures.
Try this
- Check the subjectAsk whether the study used cells, animals or people.
- Check the sizeCount the participants, and be careful with anything under a hundred.
- Check the doseSee whether the amount used maps to anything a person would take.
- Check the controlLook for a comparison group and whether researchers were blinded.
- Read the limitsFind the paragraph where the authors say what they could not show.
If you enjoy mushrooms anyway
If you are an adult who uses psilocybin for other reasons, I would enjoy it for what it is, not as an anti-aging pill. Our dosing guide sets out six levels, from a microdose of 0.1 to 0.25 g. The Microdosing Bundle holds three Golden Teacher formats, so you can learn which suits you. The Golden Teacher Chocolate Bar uses 55% Belgian dark chocolate, and a little goes a long way.
What else does research say about psilocybin and the body?
Most of it is early and small, and I keep it in that box. A 2021 analysis by Simonsson and colleagues of a large US survey found that people who had ever used a classic psychedelic had lower odds of heart disease and diabetes in the past year. That is a link in survey data, not proof of an effect.
Liver and metabolism
People ask about the liver too. The site’s research on shrooms and the liver covers that question, and my piece on the psilocybin metabolism study looks at a 2026 mouse study on weight and liver fat. Like this one, it is mouse work, and I would read it with the same care whether you are in Guelph or anywhere else in Canada.
FAQ
Does psilocybin increase lifespan?
It has not been shown in people. In one 2025 mouse study, 80% of old female mice given monthly psilocybin were alive after 10 months against 50% of untreated mice, but the study ended there, so total lifespan was not measured.
Does psilocybin lengthen telomeres?
In one lab study, telomeres held their length in human cells grown with psilocin, while untreated aging cells lost length. That was in a dish. No study has measured telomeres in people taking psilocybin.
Can microdosing slow aging?
There is no evidence that it can. The mouse study used large monthly doses, not microdoses, and long-term microdosing has its own open safety questions, including a possible heart valve risk.
Is the psilocybin anti-aging study reliable?
It is a careful first step, published in a peer-reviewed journal, but it is small, used only female mice and was not blinded. The authors themselves call for more studies.
Find your strain, then your dose
Every product on the shelf shows its potency rating and the effects people report. The dosing guide walks through amounts before you order, and a real person answers if you write to us.
About the author
Lily Pelenis
I'm a Toronto-based lifestyle coach, psilocybin enthusiast and certified yoga instructor. I guide people toward mindful, balanced living, and my coaching blends modern wellness practices with ancient wisdom to help clients find deeper self-awareness, resilience and joy.
I've been experimenting with shrooms for over a decade, and I write about my own experience. I love nature, psychology and humans. That is why my articles tend to follow a trip past its peak and into the weeks after it.
Some pieces start with a strain I have tried myself, such as Golden Teacher or Albino Roller Coaster. Others are the practical ones, like how much to take the first time or how to brew a tea that sits easier on the stomach. Over the years I've learned that intention is everything, so I write about why you are taking it before I get to how.
50% off your first order
New strains, restocks, sales and new writing from the Notebook, by email. No spam, unsubscribe any time.









